Chase Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History

Chase Investment Counsel’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$232K	Hold	3,838	–	–	0.06%	138
2025 Q4	$207K	Sell	3,838 -2,234	-37%	-$107K	0.06%	129
2025 Q3	$273K	Buy	+6,072	New	+$284K	0.08%	118
2025 Q2	–	Sell	-3,438	Closed	-$209K	–	135
2025 Q1	$209K	Buy	+3,438	New	+$200K	0.08%	122
2021 Q4	–	Sell	-3,510	Closed	-$207K	–	116
2021 Q3	$207K	Buy	+3,510	New	+$231K	0.09%	97
2020 Q2	–	Sell	-87,741	Closed	-$4.89M	–	97
2020 Q1	$4.89M	Buy	87,741 +34,036	+63%	+$2.08M	3.3%	7
2019 Q4	$3.45M	Buy	+53,705	New	+$3.08M	1.75%	20

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Chase Investment Counsel's BMY Position: Q1 2026 in Review

Chase Investment Counsel held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 3,838 shares worth $232K. The position accounts for 0.06% of the portfolio, ranked #138.

Chase Investment Counsel first reported a position in BMY in Q4 2019 and has held it in 7 quarters since. The position peaked at $4.89M in Q1 2020. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Chase Investment Counsel held 3,838 shares of Bristol-Myers Squibb worth $232K as of Q1 2026.
Chase Investment Counsel left its Bristol-Myers Squibb share count unchanged in Q1 2026.
Bristol-Myers Squibb made up 0.06% of Chase Investment Counsel's portfolio in Q1 2026, its #138 holding.
Chase Investment Counsel first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 7 quarters since.
Chase Investment Counsel's Bristol-Myers Squibb position peaked at $4.89M in Q1 2020.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Chase Investment Counsel's 13F filing for Q1 2026, filed 12 May 2026.